Caplin Point Laboratories Limited (CAPLIPOINT) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE475E01026
Key metrics
- Market Cap
- ₹19,135 Cr
- P/E Ratio
- 28.82
- EPS
- 87.35
- Book Value
- 477.66
- P/B Ratio
- 5.27
- ROE
- 17.66%
- ROCE
- 18.93%
- Debt / Equity
- 0
- Net Margin
- 29.32%
- Revenue Growth
- 12.89%
- Profit Growth
- 19.57%
- Dividend Yield
- 0.32%
- 52W High
- ₹2,699.00
- 52W Low
- ₹1,500.30
- Market Cap Band
- mid cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Caplin Point Laboratories Limited
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
- Headquarters
- Chennai, India
- Promoter Holding
- 73.44%
The full Caplin Point Laboratories Limited analysis
Create a free account to open the complete CAPLIPOINT deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.